CCL15 is expressed in T and B lymphocytes, NK cells, monocytes and monocyte derived dendritic cells. It is chemotactic for T-cells and monocytes, but not neutrophils, eosinophils, or B-cells. CCL15 acts mainly via CCR1. Serum CCL15 may be a specific proteomic biomarker of hepatocellular carcinoma and lung cancer survival time.
This analyte is not currently part of Myriad RBM's testing menu.
The systemic exercise-released chemokine lymphotactin/XCL1 modulates in vitro adult hippocampal precursor cell proliferation and neuronal differentiation. (2019) Leiter O, Bernas SN, Seidemann S, Overall RW, Horenburg C, Kowal S, Kempermann G, Walker TL Scientific Reports
Networks of blood proteins in the neuroimmunology of schizophrenia (2018) Jeffries CD, Perkins DO, Fournier M, Do KQ, Cuenod M, Khadimallah I, Domenici E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW Transl Psychiatry